Canada Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program Rowan DunneSeptember 1, 2022
Canada Mindset Pharma discovers 3 novel next-gen psychedelic compounds Discovery of new drugs follows company decision to extend research outside of tryptamine class, i.e. psilocybin and DMT Rowan DunneAugust 31, 2022
Canada Chorus Aviation subsidiary sells aircraft and makes bank Falko Regional Aircraft is an asset manager and aircraft leaser and its team has a considerable track record of selling aircraft. Joseph MortonAugust 31, 2022
Canada Cybin administers psychedelic analogue to patients with major depression First novel psilocybin compound to commence clinical development marks 'tremendous milestone' for biotechnology company Rowan DunneAugust 30, 2022
Canada PharmAla Biotech applies for patent on 6 novel MDMA-like molecules Application follows successful pre-clinical animal studies at the University of Arkansas Rowan DunneAugust 29, 2022
Canada Clearmind’s psychoactive drug shows positive results for cocaine use disorder Novel proprietary psychedelic molecule continues to demonstrate potential for treating cocaine dependency Rowan DunneAugust 26, 2022
Business Tilray Medical launches new ‘CannaPoints” program The company also released 7 new products under its Tilray and Aphria brands Natalia Buendia CalvilloAugust 25, 2022
Canada Nextleaf adds THC-free CBD distillate to Glacial Gold catalogue Rise & Shine CBD Drops will initially be available in British Columbia followed by national distribution this fall Rowan DunneAugust 24, 2022
Canada Canntab Therapeutics enters the Nova Scotia cannabis marketplace Cannabinoid tablet supplier expands its Canadian distribution network Rowan DunneAugust 22, 2022
Canada PharmAla Biotech becomes first public company producing GMP MDMA Biotechnology organization will also supply LaNeo product to Australian research institute for clinical trial Rowan DunneAugust 22, 2022